Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

FDA inspection history in Roseburg, Oregon, 2018 to 2022

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2018: one Form 483; 2021: one Form 483; 2022: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018One Form 483, at Roseburg, Oregon.
  2. 2018The longest 483 on file: 10 observations over 9 pages at Roseburg, Oregon.
  3. 2021–22One Form 483 and one warning letter, at Roseburg, Oregon.

Cited most

Across all Hiers Enterprises, LLC dba Northwest Compounding Pharmacy observations on file

The complete Hiers Enterprises, LLC dba Northwest Compounding Pharmacy file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2022-09-22Warning letter Warning letter$99
2021-11-10483 Form 483$99
2018-11-14483 Form 483$99

Investigators on these documents

Bryan L. McGuckin (1)Christopher R. Czajka (1)

FEI number 3014745182 · most recent document Sep 22, 2022

About Hiers Enterprises, LLC dba Northwest Compounding Pharmacy

How many FDA Form 483s has Hiers Enterprises, LLC dba Northwest Compounding Pharmacy received?

FDA Intel has 2 Form 483s on file for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy; the most recent is dated Nov 10, 2021.

When was Hiers Enterprises, LLC dba Northwest Compounding Pharmacy last inspected by FDA?

The most recent FDA inspection document on file for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy is a Form 483 dated Nov 10, 2021, for the site in Roseburg, Oregon.

What did FDA cite at Hiers Enterprises, LLC dba Northwest Compounding Pharmacy?

The regulations cited most in the observations on file for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy are 21 CFR 211.42 (Design and construction features), 3 times; FDCA 501(a)(2)(A) (Insanitary conditions), 3 times; 21 CFR 211.165 (Testing and release for distribution), 2 times.

Has Hiers Enterprises, LLC dba Northwest Compounding Pharmacy received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Hiers Enterprises, LLC dba Northwest Compounding Pharmacy; the most recent is dated Sep 22, 2022.